SEARCH RESULTS FOR: ("曲奇软fufu-白丝女儿服V2曲奇软fufu #白丝 #女儿服")(2235 results)

Export results
Filters
Sort By
40
Results Per Page
40
Results/Pg
Company Name Brand Name GMDN Term Name GMDN Term Status FDA Product Code Name FDA Product Code Device Packaged As Sterile Sterilization Prior To Use Issuing Agency Device Size Device Size Type Device Class Implantable

Show Filters

STOCK 4 - B80010095200050

No Description
UTAK LABORATORIES, INC.
STK 4 WB V2 BD 22
In Commercial Distribution

  • B80010095200051 ()
  • B80010095200050 ()
  • B80010095200052 ()
  • B80010095200053 ()
  • B80010095200056 ()
  • B80010095200057 ()
  • B80010095200058 ()


  • Multiple heavy metal IVD, control

STOCK 3 - B80010095200040

No Description
UTAK LABORATORIES, INC.
STK 3 WB V2 BD 22
In Commercial Distribution

  • B80010095200041 ()
  • B80010095200040 ()
  • B80010095200042 ()
  • B80010095200043 ()
  • B80010095200046 ()
  • B80010095200047 ()
  • B80010095200048 ()


  • Multiple heavy metal IVD, control

DRUGS OF ABUSE QC 3 - B800DAUQC3V2FBILH0

DRUGS OF ABUSE QC 3
UTAK LABORATORIES, INC.
DAU QC 3 V2 F BILH
In Commercial Distribution

  • B800DAUQC3V2FBILH5 ()
  • B800DAUQC3V2FBILH0 ()

  • Total Volume: 2 Milliliter
DAU QC 3 V2 F BILH

  • Multiple-type clinical chemistry analyte profile IVD, control

DRUGS OF ABUSE QC 1 - B800DAUQC1V2FBILH0

DRUGS OF ABUSE QC 1
UTAK LABORATORIES, INC.
DAU QC 1 V2 F BILH
In Commercial Distribution

  • B800DAUQC1V2FBILH5 ()
  • B800DAUQC1V2FBILH0 ()

  • Total Volume: 2 Milliliter
DAU QC 1 V2 F BILH

  • Multiple-type clinical chemistry analyte profile IVD, control

DRUGS OF ABUSE POSITIVE - B800DAUPOSV2UFPHHC0

DRUGS OF ABUSE POSITIVE
UTAK LABORATORIES, INC.
DAU POS V2 U F PHHC
In Commercial Distribution

  • B800DAUPOSV2UFPHHC5 ()
  • B800DAUPOSV2UFPHHC0 ()

  • Total Volume: 3 Milliliter
DAU POS V2 U F PHHC

  • Multiple-type clinical chemistry analyte profile IVD, control

DRUGS OF ABUSE CAL LEVEL 2 - B800DAULLEVEL2V2URMC0

DRUGS OF ABUSE CAL LEVEL 2
UTAK LABORATORIES, INC.
DAU+ L LEVEL 2 V2 URMC
In Commercial Distribution

  • B800DAULLEVEL2V2URMC5 ()
  • B800DAULLEVEL2V2URMC0 ()

  • Total Volume: 5 Milliliter
DAU+ L LEVEL 2 V2 URMC

  • Multiple drugs of abuse IVD, control

DRUGS OF ABUSE CAL LEVEL 1 - B800DAULLEVEL1V2URMC0

DRUGS OF ABUSE CAL LEVEL 1
UTAK LABORATORIES, INC.
DAU+ L LEVEL 1 V2 URMC
In Commercial Distribution

  • B800DAULLEVEL1V2URMC5 ()
  • B800DAULLEVEL1V2URMC0 ()

  • Total Volume: 5 Milliliter
DAU+ L LEVEL 1 V2 URMC

  • Multiple drugs of abuse IVD, control

DRUGS OF ABUSE LEVEL 3 - B800DAU3V2FUVMG0

DRUGS OF ABUSE LEVEL 3
UTAK LABORATORIES, INC.
DAU 3 V2 F U VMG
In Commercial Distribution

  • B800DAU3V2FUVMG0 ()
  • B800DAU3V2FUVMG05 ()
  • B800DAU3V2FUVMG5 ()

  • Total Volume: 10 Milliliter
DAU 3 V2 F U VMG

  • Multiple drugs of abuse IVD, control

DRUGS OF ABUSE LEVEL 2 - B800DAU2V2FUVMG0

DRUGS OF ABUSE LEVEL 2
UTAK LABORATORIES, INC.
DAU 2 V2 F U VMG
In Commercial Distribution

  • B800DAU2V2FUVMG5 ()
  • B800DAU2V2FUVMG0 ()

  • Total Volume: 10 Milliliter
DAU 2 V2 F U VMG

  • Multiple therapeutic drugs/drugs of abuse IVD, control

DRUGS OF ABUSE LEVEL 1 - B800DAU1V2FUVMG0

DRUGS OF ABUSE LEVEL 1
UTAK LABORATORIES, INC.
DAU 1 V2 F U VMG
In Commercial Distribution

  • B800DAU1V2FUVMG5 ()
  • B800DAU1V2FUVMG0 ()

  • Total Volume: 10 Milliliter
DAU 1 V2 F U VMG

  • Multiple drugs of abuse IVD, control

VORICONAZOLE PLUS 3 - B800VOR3V2SFUNC0

VORICONAZOLE PLUS 3
UTAK LABORATORIES, INC.
VOR+ 3 V2 S F UNC
In Commercial Distribution

  • B800VOR3V2SFUNC5 ()
  • B800VOR3V2SFUNC0 ()

  • Total Volume: 2 Milliliter
VOR+ 3 V2 S F UNC

  • Multiple-therapy therapeutic drug monitoring IVD, control

VORICONAZOLE PLUS 2 - B800VOR2V2SFUNC0

VORICONAZOLE PLUS 2
UTAK LABORATORIES, INC.
VOR+ 2 V2 S F UNC
In Commercial Distribution

  • B800VOR2V2SFUNC5 ()
  • B800VOR2V2SFUNC0 ()

  • Total Volume: 2 Milliliter
VOR+ 2 V2 S F UNC

  • Multiple-therapy therapeutic drug monitoring IVD, control

VORICONAZOLE PLUS 1 - B800VOR1V2SFUNC0

VORICONAZOLE PLUS 1
UTAK LABORATORIES, INC.
VOR+ 1 V2 S F UNC
In Commercial Distribution

  • B800VOR1V2SFUNC5 ()
  • B800VOR1V2SFUNC0 ()

  • Total Volume: 2 Milliliter
VOR+ 1 V2 S F UNC

  • Multiple-therapy therapeutic drug monitoring IVD, control

VOLATILES LEVEL 2 - B800VOL2V2SFRIH0

VOLATILES LEVEL 2
UTAK LABORATORIES, INC.
VOL 2 V2 S F RIH
In Commercial Distribution

  • B800VOL2V2SFRIH5 ()
  • B800VOL2V2SFRIH0 ()

  • Total Volume: 5 Milliliter
VOL 2 V2 S F RIH

  • Multiple drugs of abuse IVD, control

VOLATILES LEVEL 1 - B800VOL1V2SFRIH0

VOLATILES LEVEL 1
UTAK LABORATORIES, INC.
VOL 1 V2 S F RIH
In Commercial Distribution

  • B800VOL1V2SFRIH5 ()
  • B800VOL1V2SFRIH0 ()

  • Total Volume: 5 Milliliter
VOL 1 V2 S F RIH

  • Multiple drugs of abuse IVD, control

TESTOSTERONE 7.5 NG/DL - B800TESTO75V2SFLCMS0

TESTOSTERONE 7.5 NG/DL
UTAK LABORATORIES, INC.
TESTO 7.5 V2 S F LCMS
In Commercial Distribution

  • B800TESTO75V2SFLCMS5 ()
  • B800TESTO75V2SFLCMS0 ()

  • Total Volume: 1.1 Milliliter
TESTO 7.5 V2 S F LCMS

  • Multiple-type clinical chemistry analyte profile IVD, control

PETH LEVEL 3 - B800PETH3V2WBFMAYO0

PETH LEVEL 3
UTAK LABORATORIES, INC.
PETH 3 V2 WB F MAYO
In Commercial Distribution

  • B800PETH3V2WBFMAYO5 ()
  • B800PETH3V2WBFMAYO0 ()

  • Total Volume: 1 Milliliter
PETH 3 V2 WB F MAYO

  • Multiple-type clinical chemistry analyte profile IVD, control

OXAZEPAM GLUCURONIDE - B800OXAGLUCV2UFHCMC0

OXAZEPAM GLUCURONIDE
UTAK LABORATORIES, INC.
OXA GLUC V2 U F HCMC
In Commercial Distribution

  • B800OXAGLUCV2UFHCMC5 ()
  • B800OXAGLUCV2UFHCMC0 ()

  • Total Volume: 2 Milliliter
OXA GLUC V2 U F HCMC

  • Multiple drugs of abuse IVD, control

NICOTINE PLUS LEVEL 1 - B800NICO1V2FQCLC0

NICOTINE PLUS LEVEL 1
UTAK LABORATORIES, INC.
NICO+ 1 V2 F QC LC
In Commercial Distribution

  • B800NICO1V2FQCLC5 ()
  • B800NICO1V2FQCLC0 ()

  • Total Volume: 5 Milliliter
NICO+ 1 V2 F QC LC

  • Multiple-type clinical chemistry analyte profile IVD, control

LEAD LEVEL 1 - B800LEAD1V2WBVWDL0

LEAD LEVEL 1
UTAK LABORATORIES, INC.
LEAD 1 V2 WB V WDL
In Commercial Distribution

  • B800LEAD1V2WBVWDL5 ()
  • B800LEAD1V2WBVWDL0 ()

  • Total Volume: 15 Milliliter
LEAD 1 V2 WB V WDL

  • Multiple-type clinical chemistry analyte profile IVD, control

LEAD LEVEL 1 - B800LEAD1V2WBFCH0

LEAD LEVEL 1
UTAK LABORATORIES, INC.
LEAD 1 V2 WB F CH
In Commercial Distribution

  • B800LEAD1V2WBFCH5 ()
  • B800LEAD1V2WBFCH0 ()

  • Total Volume: 0.5 Milliliter
LEAD 1 V2 WB F CH

  • Multiple-type clinical chemistry analyte profile IVD, control

IMMUNOSUPPRESSANTS LEVEL 3 - B800IMMU3V2WBFPH0

IMMUNOSUPPRESSANTS LEVEL 3
UTAK LABORATORIES, INC.
IMMU 3 V2 WB F PH
In Commercial Distribution

  • B800IMMU3V2WBFPH5 ()
  • B800IMMU3V2WBFPH0 ()

  • Total Volume: 2 Milliliter
IMMU 3 V2 WB F PH

  • Multiple-type clinical chemistry analyte profile IVD, control

IMMUNOSUPPRESSANTS LEVEL 2 - B800IMMU2V2WBFPH0

IMMUNOSUPPRESSANTS LEVEL 2
UTAK LABORATORIES, INC.
IMMU 2 V2 WB F PH
In Commercial Distribution

  • B800IMMU2V2WBFPH5 ()
  • B800IMMU2V2WBFPH0 ()
IMMU 2 V2 WB F PH

  • Multiple-type clinical chemistry analyte profile IVD, control

IMMUNOSUPPRESSANTS LEVEL 1 - B800IMMU1V2WBFPH0

No Description
UTAK LABORATORIES, INC.
IMMU 1 V2 WB F PH
In Commercial Distribution

  • B800IMMU1V2WBFPH5 ()
  • B800IMMU1V2WBFPH0 ()

  • Total Volume: 2 Milliliter
IMMU 1 V2 WB F PH

  • Multiple-type clinical chemistry analyte profile IVD, control

GABAPENTIN PLUS - B800GABAVV2WBFMSP0

GABAPENTIN PLUS
UTAK LABORATORIES, INC.
GABA+ V V2 WB F MSP
In Commercial Distribution

  • B800GABAVV2WBFMSP5 ()
  • B800GABAVV2WBFMSP0 ()

  • Total Volume: 50 Milliliter
GABA+ V V2 WB F MSP

  • Multiple drugs of abuse IVD, control

GABAPENTIN LEVEL 2 - B800GABA2V2SMXUFPG0

GABAPENTIN LEVEL 2
UTAK LABORATORIES, INC.
GABA 2 V2 SMXU F PG
In Commercial Distribution

  • B800GABA2V2SMXUFPG5 ()
  • B800GABA2V2SMXUFPG0 ()

  • Total Volume: 2.5 Milliliter
GABA 2 V2 SMXU F PG

  • Multiple-type clinical chemistry analyte profile IVD, control

ETHYLENE GLYCOL LEVEL 2 - B800ETHGLY2V2SFRIH0

ETHYLENE GLYCOL LEVEL 2
UTAK LABORATORIES, INC.
ETHGLY 2 V2 S F RIH
In Commercial Distribution

  • B800ETHGLY2V2SFRIH0 ()
  • B800ETHGLY2V2SFRIH5 ()

  • Total Volume: 5 Milliliter
ETHGLY 2 V2 S F RIH

  • Ethylene glycol IVD, control

ETG PLUS LEVEL 3 - B800ETG3V2UFCCL0

ETG PLUS LEVEL 3
UTAK LABORATORIES, INC.
ETG+ 3 V2 U F CCL
In Commercial Distribution

  • B800ETG3V2UFCCL5 ()
  • B800ETG3V2UFCCL0 ()

  • Total Volume: 2 Milliliter
ETG+ 3 V2 U F CCL

  • Multiple-type clinical chemistry analyte profile IVD, control

ETG PLUS LEVEL 2 - B800ETG2V2UFCCL0

ETG PLUS LEVEL 2
UTAK LABORATORIES, INC.
ETG+ 2 V2 U F CCL
In Commercial Distribution

  • B800ETG2V2UFCCL5 ()
  • B800ETG2V2UFCCL0 ()

  • Total Volume: 2 Milliliter
ETG+ 2 V2 U F CCL

  • Multiple-type clinical chemistry analyte profile IVD, control

ETG PLUS LEVEL 1 - B800ETG1V2UFCCL0

ETG PLUS LEVEL 1
UTAK LABORATORIES, INC.
ETG+ 1 V2 U F CCL
In Commercial Distribution

  • B800ETG1V2UFCCL5 ()
  • B800ETG1V2UFCCL0 ()

  • Total Volume: 2 Milliliter
ETG+ 1 V2 U F CCL

  • Multiple-type clinical chemistry analyte profile IVD, control

STOCK 2 - B80010095200030

No Description
UTAK LABORATORIES, INC.
STK 2 WB V2 BD 22
In Commercial Distribution

  • B80010095200030 ()
  • B80010095200031 ()
  • B80010095200032 ()
  • B80010095200033 ()
  • B80010095200036 ()
  • B80010095200037 ()
  • B80010095200038 ()


  • Multiple heavy metal IVD, control

STOCK 1 - B80010095200020

No Description
UTAK LABORATORIES, INC.
STK 1 WB V2 BD 22
In Commercial Distribution

  • B80010095200020 ()
  • B80010095200021 ()
  • B80010095200022 ()
  • B80010095200023 ()
  • B80010095200026 ()
  • B80010095200027 ()
  • B80010095200028 ()


  • Multiple heavy metal IVD, control

ACETAMINOPHEN PLUS HIGH - B80010095200010

No Description
UTAK LABORATORIES, INC.
ACETA+ HIGH V2 S F BD
In Commercial Distribution

  • B80010095200010 ()
  • B80010095200011 ()
  • B80010095200012 ()
  • B80010095200013 ()
  • B80010095200016 ()
  • B80010095200017 ()
  • B80010095200018 ()


  • Multiple-therapy therapeutic drug monitoring IVD, control

AMPHETAMINE PLUS LEVEL 2 - B80006285000020

No Description
UTAK LABORATORIES, INC.
AMPH+ 2 U V2 F WBH
In Commercial Distribution

  • B80006285000021 ()
  • B80006285000020 ()
  • B80006285000022 ()
  • B80006285000023 ()
  • B80006285000026 ()
  • B80006285000027 ()
  • B80006285000028 ()


  • Multiple therapeutic drugs/drugs of abuse IVD, control

AMPHETAMINE PLUS LEVEL 1 - B80006285000010

No Description
UTAK LABORATORIES, INC.
AMPH+ 1 U V2 F WBH
In Commercial Distribution

  • B80006285000010 ()
  • B80006285000011 ()
  • B80006285000012 ()
  • B80006285000013 ()
  • B80006285000016 ()
  • B80006285000017 ()
  • B80006285000018 ()


  • Multiple therapeutic drugs/drugs of abuse IVD, control

Human Touch - 00045915829698

A mains electricity (AC-powered) device specifically designed to be used when placed in a bed or chair. It may be fixed into appropriate beds or chairs providing other functions. It will provide a massaging therapeutic effect to the person occupying the bed or chair typically to ease aches and pains in the body. It may be used in an institution, but is typically designed for home use.
Human Touch, LLC
HT GRAVIS PAD SET SAND V2
In Commercial Distribution

  • 00045915829698 ()
100-GRAVIS-019

  • Bed/chair electric massager

Human Touch - 00045915829681

A mains electricity (AC-powered) device specifically designed to be used when placed in a bed or chair. It may be fixed into appropriate beds or chairs providing other functions. It will provide a massaging therapeutic effect to the person occupying the bed or chair typically to ease aches and pains in the body. It may be used in an institution, but is typically designed for home use.
Human Touch, LLC
HT GRAVIS PAD SET SADDLE V2
In Commercial Distribution

  • 00045915829681 ()
100-GRAVIS-018

  • Bed/chair electric massager

Human Touch - 00045915829629

A mains electricity (AC-powered) device specifically designed to be used when placed in a bed or chair. It may be fixed into appropriate beds or chairs providing other functions. It will provide a massaging therapeutic effect to the person occupying the bed or chair typically to ease aches and pains in the body. It may be used in an institution, but is typically designed for home use.
Human Touch, LLC
HT GRAVIS PAD SET GRAY V2
In Commercial Distribution

  • 00045915829629 ()
100-GRAVIS-017

  • Bed/chair electric massager

Human Touch - 00045915829612

A mains electricity (AC-powered) device specifically designed to be used when placed in a bed or chair. It may be fixed into appropriate beds or chairs providing other functions. It will provide a massaging therapeutic effect to the person occupying the bed or chair typically to ease aches and pains in the body. It may be used in an institution, but is typically designed for home use.
Human Touch, LLC
HT GRAVIS PAD SET BLACK V2
In Commercial Distribution

  • 00045915829612 ()
100-GRAVIS-016

  • Bed/chair electric massager

Human Touch - 00045915829605

A mains electricity (AC-powered) device specifically designed to be used when placed in a bed or chair. It may be fixed into appropriate beds or chairs providing other functions. It will provide a massaging therapeutic effect to the person occupying the bed or chair typically to ease aches and pains in the body. It may be used in an institution, but is typically designed for home use.
Human Touch, LLC
HT GRAVIS PAD SET BONE V2
In Commercial Distribution

  • 00045915829605 ()
100-GRAVIS-020

  • Bed/chair electric massager
< 1 ... 51 52 53 54 55 56 >